Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Feb 23 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.80 Insider Own9.59% Shs Outstand46.97M Perf Week15.33%
Market Cap302.16M Forward P/E- EPS next Y-4.03 Insider Trans-0.13% Shs Float43.23M Perf Month11.86%
Income-228.47M PEG- EPS next Q-1.46 Inst Own79.37% Short Float8.58% Perf Quarter-6.09%
Sales111.90M P/S2.70 EPS this Y-132.90% Inst Trans-4.86% Short Ratio3.34 Perf Half Y-28.10%
Book/sh5.62 P/B1.12 EPS next Y36.22% ROA-30.26% Short Interest3.71M Perf Year-68.23%
Cash/sh13.78 P/C0.46 EPS next 5Y- ROE-66.23% 52W Range5.19 - 22.48 Perf YTD-6.65%
Dividend Est.- P/FCF- EPS past 5Y1.59% ROI-29.18% 52W High-71.89% Beta0.98
Dividend TTM- Quick Ratio9.88 Sales past 5Y399.22% Gross Margin85.27% 52W Low21.77% ATR (14)0.35
Dividend Ex-Date- Current Ratio10.11 EPS Y/Y TTM-78.62% Oper. Margin-118.78% RSI (14)57.38 Volatility5.82% 5.77%
Employees501 Debt/Eq1.94 Sales Y/Y TTM82.16% Profit Margin-204.17% Recom1.50 Target Price29.42
Option/ShortYes / Yes LT Debt/Eq1.91 EPS Q/Q-83.25% Payout- Rel Volume0.56 Prev Close6.28
Sales Surprise-95.23% EPS Surprise-120.01% Sales Q/Q-2.90% EarningsNov 07 BMO Avg Volume1.11M Price6.32
SMA209.99% SMA500.84% SMA200-33.46% Trades Volume619,173 Change0.64%
Date Action Analyst Rating Change Price Target Change
Dec-19-23Downgrade Mizuho Buy → Neutral $52 → $10
Mar-17-22Upgrade UBS Neutral → Buy $40
Jun-15-21Initiated BTIG Research Buy $46
May-21-21Initiated UBS Neutral $40
Apr-26-21Resumed Credit Suisse Outperform $78
Apr-01-21Upgrade Mizuho Neutral → Buy $52
Jan-07-21Upgrade Guggenheim Neutral → Buy $62
Nov-24-20Initiated H.C. Wainwright Buy $80
Nov-11-20Initiated Berenberg Buy
Nov-09-20Initiated Jefferies Buy $55
Dec-19-23 07:15AM
Dec-11-23 07:30PM
Dec-10-23 11:59AM
Dec-08-23 07:05AM
04:08AM Loading…
Nov-29-23 07:05AM
Nov-14-23 10:31PM
Nov-08-23 09:55AM
Nov-07-23 08:25AM
Oct-30-23 09:32AM
Oct-27-23 10:00AM
02:14PM Loading…
Oct-26-23 02:14PM
Oct-25-23 10:02AM
Oct-24-23 07:05AM
Oct-12-23 08:24AM
Oct-06-23 11:31AM
Oct-05-23 01:49PM
Oct-02-23 07:05AM
Sep-05-23 01:10PM
Sep-01-23 06:51PM
Aug-31-23 10:12PM
03:51PM Loading…
Aug-26-23 03:51PM
Aug-06-23 08:05AM
Aug-01-23 09:05AM
Jul-27-23 08:35PM
Jun-28-23 09:20AM
Jun-26-23 07:11AM
Jun-22-23 03:03PM
Jun-21-23 08:00PM
Jun-20-23 07:05AM
Jun-16-23 07:05AM
May-15-23 07:53AM
May-14-23 08:16AM
May-09-23 08:25AM
May-02-23 04:40PM
Apr-26-23 08:00PM
Apr-17-23 10:31AM
Mar-13-23 07:05AM
Mar-10-23 09:07AM
Mar-02-23 07:05AM
Feb-28-23 04:19PM
Feb-27-23 08:25AM
Feb-23-23 08:05AM
Feb-21-23 07:05AM
Jan-31-23 07:05AM
Jan-06-23 05:39AM
Dec-20-22 07:05AM
Dec-16-22 07:15AM
Dec-10-22 10:00AM
Nov-29-22 11:00AM
Nov-23-22 05:30PM
Nov-22-22 04:40PM
Nov-17-22 07:05AM
Nov-10-22 09:55AM
Nov-02-22 08:35AM
Oct-17-22 10:00AM
Oct-11-22 07:05AM
Oct-03-22 07:05AM
Sep-06-22 07:05AM
Aug-14-22 08:23AM
Aug-08-22 11:53AM
Aug-02-22 12:34PM
Jul-21-22 05:25PM
Jul-11-22 03:00AM
Jul-09-22 01:09PM
Jul-03-22 09:05AM
Jun-24-22 10:30AM
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolmetsch RicardoPresident, R&DSep 18Sale7.465,84143,574163,404Sep 20 04:45 PM
CALOZ PIERREChief Operating OfficerJul 10Sale11.3615,117171,72995,098Jul 12 04:49 PM
Gut RobertDirectorJun 16Sale18.883,22860,94547,669Jun 20 05:20 PM
CALOZ PIERREChief Operating OfficerJun 16Sale18.802,92054,896110,215Jun 20 05:14 PM
Soteropoulos PaulaDirectorJun 16Sale18.992,27543,20222,423Jun 20 05:30 PM
Balachandran MadhavanDirectorJun 16Sale18.912,28343,17225,990Jun 20 05:17 PM
Jacques Rachelle SuzanneDirectorJun 16Sale18.762,30143,16716,629Jun 20 05:33 PM
Meek David D.DirectorJun 16Sale18.852,29043,16622,481Jun 20 05:25 PM
Kaye JackDirectorJun 16Sale18.932,28043,16034,119Jun 20 05:23 PM
Springhorn Jeremy P.DirectorJun 16Sale18.882,28643,16025,987Jun 20 05:06 PM
POST LEONARD EDirectorJun 16Sale18.832,29143,14018,221Jun 20 05:28 PM
KLEMT CHRISTIANChief Financial OfficerJun 16Sale18.941,58730,058132,854Jun 20 05:11 PM
Kapusta Matthew CCEO, Managing DirectorMar 07Sale21.392,52153,924468,743Mar 09 04:58 PM
CALOZ PIERREChief Operating OfficerMar 07Sale21.3399021,117113,135Mar 09 05:16 PM
KLEMT CHRISTIANChief Financial OfficerMar 07Sale21.3698621,061134,441Mar 09 05:05 PM
Dolmetsch RicardoPresident, R&DMar 07Sale21.0483717,610169,245Mar 09 05:01 PM
Kuta Alexander Edward IIIExecutive VP, OperationsMar 07Sale21.3658512,49690,381Mar 09 05:09 PM
Kapusta Matthew CCEO, Managing DirectorFeb 28Sale20.905,021104,939471,264Mar 01 04:13 PM
Gut RobertDirectorFeb 28Sale21.161,43130,28042,197Mar 01 04:09 PM
KLEMT CHRISTIANChief Financial OfficerFeb 28Sale20.901,36928,612135,427Mar 01 04:15 PM
Kuta Alexander Edward IIIExecutive VP, OperationsFeb 28Sale21.041,21225,50090,966Mar 01 04:17 PM
Kapusta Matthew CCEO, Managing DirectorFeb 27Sale19.8919,526388,313476,285Mar 01 04:13 PM
KLEMT CHRISTIANChief Financial OfficerFeb 27Sale20.109,824197,462136,796Mar 01 04:15 PM
Dolmetsch RicardoPresident, R&DFeb 27Sale19.586,944135,964170,082Mar 01 04:14 PM
Kuta Alexander Edward IIIExecutive VP, OperationsFeb 27Sale19.995,514110,22592,178Mar 01 04:17 PM
CALOZ PIERREChief Operating OfficerFeb 27Sale19.614,36585,608114,125Mar 01 04:16 PM
Gut RobertDirectorFeb 27Sale19.7953710,62743,628Mar 01 04:09 PM
Springhorn Jeremy P.DirectorFeb 27Sale20.413847,83719,573Mar 01 04:12 PM
Jacques Rachelle SuzanneDirectorFeb 27Sale20.023847,68810,230Mar 01 04:11 PM
Kaye JackDirectorFeb 27Sale19.993847,67627,699Mar 01 04:10 PM
Balachandran MadhavanDirectorFeb 27Sale19.993847,67619,573Mar 01 04:17 PM
POST LEONARD EDirectorFeb 27Sale19.733897,67511,812Mar 01 04:19 PM
Soteropoulos PaulaDirectorFeb 27Sale19.973847,66815,998Mar 01 04:16 PM
Meek David D.DirectorFeb 27Sale19.713897,66716,071Mar 01 04:09 PM